DataMeds AI (MEDS) Non-Current Assets (2024 - 2026)

DataMeds AI (MEDS) has reported Non-Current Assets for 3 consecutive years, with $27.4 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 34.08% year-over-year to $27.4 million; the trailing twelve-month figure through Mar 2026 stood at $135.7 million (changed N/A YoY), and the FY2025 full-year result was $27.6 million, down 34.45% from the prior year.
• Non-Current Assets eased to $27.4 million in Q1 2026 per MEDS's latest filing, from $27.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $42.2 million in Q4 2024 and bottomed at $27.4 million in Q1 2026.
• Historically, Non-Current Assets has averaged $36.6 million across 3 years, with a median of $40.3 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Non-Current Assets slumped 34.45% in 2025, then slumped 34.08% in 2026.
• Over 3 years, Non-Current Assets stood at $42.2 million in 2024, then plunged by 34.45% to $27.6 million in 2025, then retreated by 0.99% to $27.4 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $27.4 million, $27.6 million, and $40.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.